Perrigo Advances Consumer Self-Care Growth Strategy With Acquisition Of Prevacid®24hr
Perrigo Company plc Ordinary Shares (PRGO)
Last perrigo company plc ordinary shares earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
perrigo.investorroom.com
Company Research
Source: PR Newswire
DUBLIN, Sept. 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have the exclusive rights to market, sell and distribute Prevacid®24HR in the United States OTC market. Financial terms of the agreement were not disclosed.Prevacid®24HR treats frequent heartburn (occurring 2 or more days a week) and is not intended for immediate relief of heartburn. Perrigo CEO and President Murray S. Kessler commented, "This acquisition of the well-established brand Prevacid®24HR is another example of how tuck-in acquisitions can expand our robust self-care portfolio. This margin accretive asset strengthens our leadership position in a core category and is expected to accelerate brand and category growth. I am confident our team can enhance the value of the Prevacid® brand. Perrigo is in the unique posit
Show less
Read more
Impact Snapshot
Event Time:
PRGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRGO alerts
High impacting Perrigo Company plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRGO
News
- Perrigo gets offer to sell its HRA Pharma rare diseases unit [Seeking Alpha]Seeking Alpha
- Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million [Yahoo! Finance]Yahoo! Finance
- Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionPR Newswire
- Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024PR Newswire
PRGO
Earnings
- 2/27/24 - Beat
PRGO
Sec Filings
- 4/25/24 - Form 8-K
- 4/9/24 - Form 4
- 4/9/24 - Form 4
- PRGO's page on the SEC website